Pharmacogenomics - Implications in the Development of HIV-Associated Brain Disease

E-ISSN： 1875-614x|8|2|164-168

ISSN： 1871-5230

Source： Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol.8, Iss.2, 2009-01, pp. : 164-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cross-Talk Between NO Synthase Isoforms in Neuro-Inflammation: Possible Implications in HIV-Associated Neurocognitive Disorders

Current Medicinal Chemistry, Vol. 23, Iss. 24, 2016-07 ,pp. : 2706-2714

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic options for HIV-associated lymphomas

By Spina Michele Gloghini Annunziata Tirelli Umberto Carbone Antonino

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2471-2481

Informa Healthcare

Access to resources Recommend Favorite

Somatropin promising in HIV-associated lipodystrophy

Inpharma, Vol. 1, Iss. 1311, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

HIV-Associated Peripheral Neuropathy: Epidemiology, Pathophysiology and Treatment

By Wulff E.A. Wang A.K. Simpson D.M.

Drugs, Vol. 59, Iss. 6, 2000-06 ,pp. : 1251-1260

Adis International

Access to resources Recommend Favorite

Antiretrovirals: HIV-associated lipodystrophy: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1335, 2011-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite